PlainRecalls
FDA Drug Moderate Class II Terminated

Adrenalin (epinephrine injection, USP) 30 mg/30 mL (1mg/mL), 30 mL multiple dose vial, Rx only, MFG: Par Pharma, NDC 42023-168-01

Reported: June 15, 2022 Initiated: April 13, 2022 #D-1022-2022

Product Description

Adrenalin (epinephrine injection, USP) 30 mg/30 mL (1mg/mL), 30 mL multiple dose vial, Rx only, MFG: Par Pharma, NDC 42023-168-01

Reason for Recall

cGMP deviations: Temperature abuse

Details

Units Affected
58 cartons
Distribution
USA nationwide.
Location
Richmond, VA

Frequently Asked Questions

What product was recalled?
Adrenalin (epinephrine injection, USP) 30 mg/30 mL (1mg/mL), 30 mL multiple dose vial, Rx only, MFG: Par Pharma, NDC 42023-168-01. Recalled by Mckesson Medical-Surgical Inc. Corporate Office. Units affected: 58 cartons.
Why was this product recalled?
cGMP deviations: Temperature abuse
Which agency issued this recall?
This recall was issued by the FDA Drug on June 15, 2022. Severity: Moderate. Recall number: D-1022-2022.